These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A protocol to manage malignant hyperthermia with general anesthesia. Roberts MW Pediatr Dent; 1993; 15(1):45-6. PubMed ID: 7901841 [No Abstract] [Full Text] [Related]
5. Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy. Kadar AG; Kramer BA; Barth MC; White PF Anesth Analg; 2001 May; 92(5):1171-2. PubMed ID: 11323342 [No Abstract] [Full Text] [Related]
6. [Anesthesia in hereditary peripheral muscular disease]. Islander G; Jungner M Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909 [No Abstract] [Full Text] [Related]
7. Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo model. Metterlein T; Schuster F; Palmer E; Roewer N; Anetseder M Muscle Nerve; 2011 Aug; 44(2):213-6. PubMed ID: 21607984 [TBL] [Abstract][Full Text] [Related]
8. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure]. Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782 [No Abstract] [Full Text] [Related]
9. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia. Dexter F; Epstein RH; Wachtel RE; Rosenberg H Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104 [TBL] [Abstract][Full Text] [Related]
12. Anesthetic Management of Coronary Artery Bypass Grafting in a Patient with Charcot-Marie-Tooth Disease and Multivessel Coronary Artery Disease. Rawson J; Hayanga JWA; Varga JL; Bozek JS; Hayanga HK Am J Case Rep; 2023 Dec; 24():e940284. PubMed ID: 38117749 [TBL] [Abstract][Full Text] [Related]
13. [Anesthetic management for a patient with Charcot-Marie-Tooth disease using propofol and nitrous oxide]. Sugino S; Yamazaki Y; Nawa Y; Sato K; Sonoda H; Namiki A Masui; 2002 Sep; 51(9):1016-9. PubMed ID: 12382395 [TBL] [Abstract][Full Text] [Related]
14. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia]. Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881 [TBL] [Abstract][Full Text] [Related]
15. Anesthesia and electroconvulsive therapy: when succinylcholine is contraindicated. González A; Benavides J; Lema G J ECT; 2013 Mar; 29(1):75-6. PubMed ID: 23422522 [No Abstract] [Full Text] [Related]
16. The place of suxamethonium in pediatric anesthesia. Rawicz M; Brandom BW; Wolf A Paediatr Anaesth; 2009 Jun; 19(6):561-70. PubMed ID: 19645973 [TBL] [Abstract][Full Text] [Related]
17. An unusual case of malignant hyperthermia presenting on the acute medical take. Jones R; Shahid F; Cowell RP Br J Hosp Med (Lond); 2015 Feb; 76(2):110-1. PubMed ID: 25671478 [No Abstract] [Full Text] [Related]
18. Concepts in the prevention and management of malignant hyperthermia. Collins CP; Beirne OR J Oral Maxillofac Surg; 2003 Nov; 61(11):1340-5. PubMed ID: 14613092 [No Abstract] [Full Text] [Related]
19. Anaesthesia for Charcot-Marie-Tooth disease: a review of 86 cases. Antognini JF Can J Anaesth; 1992 Apr; 39(4):398-400. PubMed ID: 1563065 [TBL] [Abstract][Full Text] [Related]
20. [ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine]. HNO; 1995 Nov; 43(11):640-1. PubMed ID: 8530309 [No Abstract] [Full Text] [Related] [Next] [New Search]